Investigation of effects of abnormal electrolyte condition and heavy metal exposure on stability and function of therapeutic recombinant human erythropoietin (rHuEPO) in vitro
Siraprapha Sanchatjate1, Sumontha Nookabkeaw2 and Jutamaad Satayavivad2 1Translational Research Unit and 2Pharmacology Laboratory, Chulabhorn Research Institute Recombinant human erythropoietin (rHuEPO) has been widely used for treatment of anemia associated with chronic renal failure. Cases of anti-rHuEPO-associated pure red cell aplasia (PRCA) have been found in patients undergone rHuEPO treatment. Patients become resistant to administered rHuEPO… (read more)